1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. GLUCOTRACK INC

GlucoTrack Inc

XNAS: GCTK

Download real time

0.14 -0.02 (-12.50%)

New 52W Low today

1.3M XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
18W
0O
2T
1.8

Market Cap

Low in industry
-0.1

PE TTM

Negative PE TTM
0

PEG TTM

-0.1

Price to Book

Negative Price to Book
0.9

Beta 1Year

Low volatility
Board Meeting
The next board meeting for GlucoTrack Inc is on 25 Apr 2025 for the purpose of GlucoTrack Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for GlucoTrack Inc

The latest disclosure was made by Andrew K. Balo in GlucoTrack Inc where a trade of 4,490 Common Stock, par value $0.001 per share done was reported to US exchanges on March 26, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Andrew K. Balo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2025 4,490 4,490 - 0 Common Stock, par value $0.001 per share
john Ballantyne Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 132,036 132,036 - - Series B Common Warrant
john Ballantyne Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 132,036 132,036 - - Series A Common Warrant
john Ballantyne Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Jul 2024 59,260 59,260 - - Warrants to Purchase Common Stock
john Ballantyne Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Jul 2024 76,191 76,191 - - Warrants to Purchase Common Stock
john Ballantyne Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Jul 2024 106,667 106,667 - - Warrants to Purchase Common Stock
john Ballantyne Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 4,126 4,126 - 0 Common Stock, par value $0.001 per share
john Ballantyne Director, Ten Percent Owner 30 Jul 2024 2,560,553 2,743,591 - 0 Common Stock, par value $0.001 per share
john Ballantyne Director, Ten Percent Owner Other type of transaction at price $ 31.00 per share. 30 Jul 2024 132,036 183,039 - 31 4,093,116 Common Stock, par value $0.001 per share
john Ballantyne Director, Ten Percent Owner 30 Jul 2024 132,036 0 - - Series B Common Warrant
Andrew Sycoff Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Jul 2024 138,000 138,000 - - Warrants to Purchase Common Stock
Paul V. Goode Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Jul 2024 42,000 42,000 - - Warrants to Purchase Common Stock
Paul V. Goode Director, Chief Executive Officer 14 Jun 2024 796 0 - - Series B Common Warrant
Paul V. Goode Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 796 796 - - Series B Common Warrant
Paul V. Goode Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Jun 2024 2,100 2,100 - - Warrants to Purchase Common Stock
Paul V. Goode Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 3,277 3,277 - - Stock option (right to buy)
Paul V. Goode Director, Chief Executive Officer 14 Jun 2024 15,435 18,989 - 0 Common Stock, par value $0.001 per share
Paul V. Goode Director, Chief Executive Officer Other type of transaction at price $ 0.00 per share. 14 Jun 2024 1,500 3,554 - - Common Stock, par value $0.001 per share
Paul V. Goode Director, Chief Executive Officer 14 Jun 2024 796 2,054 - 31.2 24,835 Common Stock, par value $0.001 per share
Paul V. Goode Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 796 796 - - Series A Common Warrant
Andrew Sycoff Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.26 per share. 22 Apr 2024 182,539 2,951,257 - 1.3 230,000 Common Stock
Erin Catherine Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2023 2,078 2,078 - - Series B Common Warrant
Erin Catherine Carter Director 31 Dec 2023 2,078 0 - - Series B Common Warrant
Erin Catherine Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2023 2,078 2,078 - - Series A Common Warrant
Erin Catherine Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2023 1,896 45,632 - 0 Common Stock, par value $0.001 per share
Erin Catherine Carter Director 31 Dec 2023 40,297 43,736 - 0 Common Stock, par value $0.001 per share
Erin Catherine Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2023 458 1,361 - 0 Common Stock, par value $0.001 per share
Erin Catherine Carter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Dec 2023 903 903 - 0 Common Stock, par value $0.001 per share
Erin Catherine Carter Director 31 Dec 2023 2,078 3,439 - 31.2 64,834 Common Stock, par value $0.001 per share
Allen E. Danzig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2022 1,498 1,922 - 0 Common Stock, par value $0.001 per share
Allen E. Danzig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2022 229 424 - 0 Common Stock, par value $0.001 per share
Allen E. Danzig Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Oct 2022 44 195 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 121 272 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 362 634 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 489 1,123 - 0 Common Stock, par value $0.001 per share
Luis Malave Director 30 Sep 2021 6,886 8,009 - 31.2 214,843 Common Stock, par value $0.001 per share
Luis Malave Director 30 Sep 2021 133,532 141,541 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 2,076 143,617 - 0 Common Stock, par value $0.001 per share
Luis Malave Director 30 Sep 2021 6,886 0 - - Series B Common Warrant
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 6,886 6,886 - - Series A Common Warrant
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 6,886 6,886 - - Series B Common Warrant
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 8 8 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 11 19 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 25 44 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 34 78 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 44 122 - 0 Common Stock, par value $0.001 per share
Luis Malave Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Sep 2021 29 151 - 0 Common Stock, par value $0.001 per share
Robert Fischell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 318 318 - 0 Common Stock, par value $0.001 per share
Robert Fischell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 1,498 2,045 - 0 Common Stock, par value $0.001 per share
Robert Fischell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Aug 2021 229 547 - 0 Common Stock, par value $0.001 per share
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters